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Abstract 
The etiology of gastric antral vascular ectasia (GAVE) and hyperplastic polyps (HP) is not 
fully understood, but there is no known overlap. We report a case of gastroduodenal HP 
arising in a patient treated for GAVE. 
 
Case Report 
A hospitalized 55-year-old male was evaluated for intermittent melena and transfusion dependent 
anemia 4 months post cardiac transplantation for ischemic cardiomyopathy. His comorbidities included 
graft failure requiring a biventricular assist device with anticoagulation, hemodialysis dependent renal 
failure, and cytomegalovirus viremia. His medications included cyclosporine, prednisone, warfarin, and 
pantoprazole. Liver disease was suggested by a nodular liver and mild splenomegaly on imaging, with 
intact synthetic function and negative serologic testing. On endoscopy GAVE was treated with gold 
probe cautery (GPC) (fig. 1). Duodenal biopsies taken for an appearance of duodenitis showed 
hemosiderin laden macrophages and were negative for cytomegalovirus. Colonoscopy was normal. 
Serial endoscopies for persistent symptoms over the following 12 months revealed antral arteriovenous 
malformations (AVM) treated with GPC, congestive gastropathy, but also evolving mucosal nodularity 
in the duodenum, and finally antral and duodenal polyps (fig. 2). The largest polyp (antral, 1.5 cm) was 
removed and confirmed as hyperplastic (fig. 3). The patient expired later due to unrelated infectious 
complications. 
Discussion 
Despite unclear etiologic overlap, this and previous cases [1, 2] may suggest a possible 
connection between GAVE and HP.  
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In this case, conditions that may be associated with GAVE include possible cirrhosis, 
transplantation, cardiac and renal failure. Portal hypertension can be present in 31% of 
patients with GAVE, with diffuse antral rather than typical watermelon pattern [3]. It may 
be mediated by factors other than simple vascular congestion, such as altered antral 
pyloric motility [4, 5]. Bone marrow transplantation is associated with GAVE through 
unclear mechanisms [6], but there is no known association with solid organ 
transplantation. Congestive heart failure has been associated with congestive 
gastroduodenopathy and vascular ectasia [7], and the use of a ventricular assist device has 
been associated with AVM [8]. Vascular ectasia has also been associated with renal failure 
and hemodialysis [9]. 
HP account for more than 50% of gastric polyps, are considered benign, and may 
present with anemia or mechanical obstruction. Though their malignant potential is low, 
it is present, particularly with polyps >5 mm [10]. There is evidence supporting clonality 
and neoplastic potential of gastric HP [11]. The etiology of gastric HP is not known, but 
there is an association with atrophic gastritis, Helicobacter pylori infection, and elevated 
gastrin levels [12]. Gastric HP have been reported with proton pump inhibitor therapy 
[13]. Duodenal HP may represent hyperplasia of Brunner’s glands. Gastroduodenal 
mucosal hyperplasia has been reported in patients with chronic renal failure [14] and 
hemodialysis [15], possibly due to a trophic effect of hypergastrinemia and 
hyperpepsinogenemia. HP have also been reported post solid organ transplantation [16], 
possibly in association with immunosuppression and CMV infection [17], which has been 
associated with foveolar gastric hyperplasia [18]. 
Vascular ectasia and HP can in this case be explained independently, with renal disease 
as the only potential common etiologic factor. Nevertheless HP have been reported 
following treatment of GAVE [1, 2], and gastric ulcers [19] without underlying renal 
disease. Based on the temporal relationship and current data, a multifactorial process may 
be at play. Trophic and genetic factors may result in hyperplastic changes, particularly in 
new mucosa at healing sites of treated GAVE. Such an association may have clinical 
relevance in therapeutic endoscopy in patients with chronic renal and liver disease and in 
transplant recipients. 
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Fig. 1. a Gastric antrum with vascular ectasia prior to endoscopic treatment. b Duodenum with 
punctuate erythema and possible duodenitis on initial endoscopy. 
 
 
Fig. 2. a Gastric antral polyps 12 months after initial endoscopic treatment of GAVE. b Duodenal 
polyps 12 months after initial endoscopy. 
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Fig. 3. Hyperplastic polyp with cystically dilated, branched foveolar epithelium and stromal edema. 
H&E stain, magnification ×40. 
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